Pharmacokinetics of oral doxycycline and concentrations in body fluids and bronchoalveolar cells of foals

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue 3, 2007, Pages 187-193

  Womble, A ^a   Giguere S ^a   Lee, E A ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL VIRULENCE; BETA HEMOLYTIC STREPTOCOCCUS; BRONCHUS; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CONCENTRATION; DRUG DISPOSITION; DRUG HALF LIFE; DRUG SCREENING; FEMALE; FOAL; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FLUID; MALE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PERITONEAL FLUID; PRIORITY JOURNAL; RHODOCOCCUS EQUI; SERUM; SYNOVIAL FLUID; URINE;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; ASCITIC FLUID; BRONCHOALVEOLAR LAVAGE FLUID; CEREBROSPINAL FLUID; CROSS-OVER STUDIES; DOXYCYCLINE; FEMALE; HORSES; MALE; SYNOVIAL FLUID;

BACTERIA (MICROORGANISMS); RHODOCOCCUS EQUI;

EID: 34247627477     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00857.x     Document Type: Article

References (43)

1. Agwuh, K.N. MacGowan, A. (2006) Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines. Antimicrobial Agents and Chemotherapy, 58, 256 265.
2. Baert, K., Croubels, S., Gasthuys, F., De Busser, J. De Backer, P. (2000) Pharmacokinetics and oral bioavailability of a doxycycline formulation (doxycycline 75%) in nonfasted young pigs. Journal of Veterinary Pharmacology and Therapeutics, 23, 45 48.
3. Baldwin, D.R., Wise, R., Andrews, J.M., Ashby, J.P. Honeybourne, D. (1990) Azithromycin concentrations at the sites of pulmonary infection. European Respiratory Journal, 3, 886 890.
4. Baldwin, D.R., Honeybourne, D. Wise, R. (1992) Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrobial Agents and Chemotherapy, 36, 1171 1175.
5. Brown, M.P., Gronwall, R., Kroll, W.R. Beal, C. (1984) Ampicillin trihydrate in foals: serum concentrations and clearance after a single oral dose. Equine Veterinary Journal, 16, 371 373.
6. Bryant, J.E., Brown, M.P., Gronwall, R.R. Merritt, K.A. (2000) Study of intragastric administration of doxycycline: pharmacokinetics including body fluid, endometrial and minimum inhibitory concentrations. Equine Veterinary Journal, 32, 233 238.
7. Bryskier, A. (2005) Tetracyclines. In Antimicrobial Agents: Antibacterials and Antifungals. Ed. Bryskier, A., pp. 642 651. ASM Press, Washington.
8. Chopra, I. Roberts, M. (2001) Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiology and Molecular Biology Reviews, 65, 232 260.
9. Cohen, N.D. (1994) Causes of and farm management factors associated with disease and death in foals. Journal of the American Veterinary Medical Association, 204, 1644 1651.
10. Conte, J.E., Golden, J., Duncan, S., McKenna, E., Lin, E. Zurlinden, E. (1996) Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. Antimicrobial Agents and Chemotherapy, 40, 1617 1622.
11. Cunha, B.A., Domenico, P. Cunha, C.B. (2000) Pharmacodynamics of doxycycline. Clinical Microbiology and Infection, 6, 270 273.
12. Davis, J.L., Salmon, J.H. Papich, M.G. (2006) Pharmacokinetics and tissue distribution of doxycycline after oral administration of single and multiple doses in horses. American Journal of Veterinary Research, 67, 310 316.
13. Dimmling, T. Vanderbeke, O. (1975) Pharmacokinetics after oral and intravenous administration of tetracycline compounds. Medizinische Klinik, 70, 279 285.
14. Duffee, N.E., Stang, B.E. Schaeffer, D.J. (1997) The pharmacokinetics of cefadroxil over a range of oral doses and animal ages in the foal. Journal of Veterinary Pharmacology and Therapeutics, 20, 427 433.
15. Ensink, J.M., Van Klingeren, B., Houwers, D.J., Klein, W.R. Vulto, A.G. (1993) In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. Equine Veterinary Journal, 25, 309 313.
16. Forsgren, A. Bellahsene, A. (1985) Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scandinavian Journal of Infectious Diseases, 44, 16 23.
17. Gabler, W.L. (1991) Fluxes and accumulation of tetracyclines by human blood cells. Research Communications in Chemical Pathology and Pharmacology, 72, 39 51.
18. Gibaldi, M. Perrier, D. (1982) Noncompartmental analysis based on statistical moment theory. In Pharmacokinetics, 2nd edn. Eds Gibaldi, M. Perrier, D., pp. 409 417. Marcel Dekker, New York.
19. Giguère, S., Gaskin, J.M., Miller, C. Bowman, J.L. (2002) Evaluation of a commercially available hyperimmune plasma product for prevention of naturally acquired pneumonia caused by Rhodococcus equi in foals. Journal of the American Veterinary Medical Association, 220, 59 63.
20. Giguère, S., Jacks, S., Roberts, G.D., Hernandez, J., Long, M.T. Ellis, C. (2004) Retrospective comparison of azithromycin, clarithromycin, and erythromycin for the treatment of foals with Rhodococcus equi pneumonia. Journal of Veterinary Internal Medicine, 18, 568 573.
21. Gilmour, M.A., Clarke, C.R., MacAllister, C.G., Dedeo, J.M., Caudell, D.L., Morton, R.J. Pugh, M. (2005) Ocular penetration of oral doxycycline in the horse. Veterinary Ophthalmology, 8, 331 335.
22. Hartnett, B.J. Marlin, G.E. (1976) Doxycycline in serum and bronchial secretions. Thorax, 31, 144 148.
23. Henry, M.M., Morris, D.D., Lakritz, J. Aucoin, D. (1992) Pharmacokinetics of cephradine in neonatal foals after single oral dosing. Equine Veterinary Journal, 24, 242 243.
24. Hoffman, A.M., Viel, L., Prescott, J.F., Rosendal, S. Thorsen, J. (1993) Association of microbiologic flora with clinical, endoscopic, and pulmonary cytologic findings in foals with distal respiratory tract infection. American Journal of Veterinary Research, 54, 1615 1622.
25. Houin, G., Brunner, F., Nebout, T., Cherfaoui, M., Lagrue, G. Tillement, J.P. (1983) The effects of chronic renal insufficiency on the pharmacokinetics of doxycycline in man. British Journal of Clinical Pharmacology, 16, 245 252.
26. Hunfeld, K.P., Bittner, T., Rodel, R., Brade, V. Cinatl, J. (2004) New real-time PCR-based method for in vitro susceptibility testing of Anaplasma phagocytophilum against antimicrobial agents. International Journal of Antimicrobial Agents, 23, 563 571.
27. Jacks, S., Giguère, S., Gronwall, P.R., Brown, M.P. Merritt, K.A. (2001) Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. American Journal of Veterinary Research, 62, 1870 1875.
28. Jacks, S., Giguère, S. Nguyen, A. (2003) In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin and 20 other antimicrobials. Antimicrobial Agents and Chemotherapy, 47, 1742 1745.
29. Marlin, G.E., Cheng, S. Thompson, P.J. (1981) Sputum and plasma doxycycline concentrations after a single oral 600 mg doxycycline dose in patients with chronic bronchitis. European Journal of Respiratory Disease, 62, 276 280.
30. Meijer, L.A., Ceyssens, K.G., de Greve, B.I. de Bruijn, W. (1993) Pharmacokinetics and bioavailability of doxycycline hyclate after oral administration in calves. The Veterinary Quarterly, 15, 1 5.
31. Meyer, F.P., Specht, H., Quednow, B. Walther, H. (1989) Influence of milk on the bioavailability of doxycycline-new aspects. Infection, 17, 245 246.
32. Nix, D.E., Goodwin, S.D., Peloquin, C.A., Rotella, D.L. Schentag, J.J. (1991) Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrobial Agents and Chemotherapy, 35, 1953 1959.
33. Nord, C.E. Heimdahl, A. (1988) Impact of different antimicrobial agents on the colonisation resistance in the intestinal tract with special reference to doxycycline. Scandinavian Journal of Infectious Diseases, 53, 50 58.
34. Pijpers, A., Schoevers, E.J., Haagsma, N. Verheijden, J.H. (1991) Plasma levels of oxytetracycline, doxycycline, and minocycline in pigs after oral administration in feed. Journal of Animal Science, 69, 4512 4522.
35. Rennard, S.I., Basset, G., Lecossier, D., O'Donnell, K.M., Pinkston, P., Martin, P.G. Crystal, R.G. (1986) Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. Journal of Applied Physiology, 60, 532 538.
36. Rikihisa, Y. Jiang, B.M. (1988) In vitro susceptibilities of Ehrlichia risticii to eight antibiotics. Antimicrobial Agents and Chemotherapy, 32, 986 991.
37. Riond, J.L. Riviere, J.E. (1990) Pharmacokinetics and metabolic inertness of doxycycline in young pigs. American Journal of Veterinary Research, 51, 1271 1275.
38. Riond, J.L., Tyczkowska, K. Riviere, J.E. (1989) Pharmacokinetics and metabolic inertness of doxycycline in calves with mature or immature rumen function. American Journal of Veterinary Research, 50, 1329 1333.
39. Riond, J.L., Riviere, J.E., Duckett, W.M., Atkins, C.E., Jernigan, A.D., Rikihisa, Y. Spurlock, S.L. (1992) Cardiovascular effects and fatalities associated with intravenous administration of doxycycline to horses and ponies. Equine Veterinary Journal, 24, 41 45.
40. Sampieri, F., Hinchcliff, K.W. Toribio, R.E. (2006) Tetracycline therapy of lawsonia intracellularis enteropathy in foals. Equine Veterinary Journal, 38, 89 92.
41. Stratton-Phelps, M., Wilson, W.D. Gardner, I.A. (2000) Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). Journal of the American Veterinary Medical Association, 217, 68 73.
42. Welling, P.G., Koch, P.A., Lau, C.C. Craig, W.A. (1977) Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects. Antimicrobial Agents and Chemotherapy, 11, 462 469.
43. Womble, A., Giguère, S., Murthy, Y.V.S.N., Cox, C. Obare, E. (2006) Pulmonary disposition of tilmicosin in foals and in vitro activity against Rhodococcus equi and other common equine bacterial pathogens. Journal of Veterinary Pharmacology and Therapeutics, 29, 561 668.